FMR LLC 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR LLC | 1,202,315 1.252% |
-4,167,047 (-77.61%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR LLC | 5,369,362 5.726% |
1,615,625 (+43.04%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR LLC | 3,753,737 10.701% |
-505,875 (-11.88%) |
Filing |
| 2021-02-10 09:23 am Purchase |
2021-02-09 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR LLC | 4,259,612 12.243% |
818,308 (+23.78%) |
Filing |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | ARS Pharmaceuticals, Inc. SPRY |
FMR LLC | 3,441,304 9.891% |
3,441,304 (New Position) |
Filing |